Related Experiment Videos
Apheresis in hematologic and oncologic disease
Hospital Practice (Office Ed.)
|October 1, 1983
Therapeutic bloodletting dates back to ancient times. With the development of sophisticated in vivo cell separators, it has become an established and effective modality in the treatment of a number of hematologic-oncologic diseases. Apheresis must, however, be used with discrimination--only when more conservative measures have proved inadequate.
Therapeutic bloodletting dates back to ancient times. With the development of sophisticated in vivo cell separators, it has become an established and effective modality in the treatment of a number of hematologic-oncologic diseases. Apheresis must, however, be used with discrimination--only when more conservative measures have proved inadequate.